Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1/JNK pathway
Authors:
Open Access
- 27 April 2024
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 150 (4) , 1-10
Abstract
Background: Targeting ferroptosis mediated by autophagy presents a novel therapeutic approach to breast cancer, a mortal neoplasm on the global scale. Pyruvate dehydrogenase kinase isozyme 4 (PDK4) has been denoted as a determinant of breast cancer metabolism. The target of this study was to untangle the functional mechanism of PDK4 in ferroptosis dependent on autophagy in breast cancer. Methods: RT-qPCR and western blotting examined PDK4 mRNA and protein levels in breast cancer cells. Immunofluorescence staining appraised light chain 3 (LC3) expression. Fe (2 +) assay estimated total iron level. Relevant assay kits and C11-BODIPY (591/581) staining evaluated lipid peroxidation level. DCFH-DA staining assayed intracellular reactive oxygen species (ROS) content. Western blotting analyzed the protein levels of autophagy, ferroptosis and apoptosis-signal-regulating kinase 1 (ASK1)/c-Jun N-terminal kinase (JNK) pathway-associated proteins. Results: PDK4 was highly expressed in breast cancer cells. Knockdown of PDK4 induced the autophagy of breast cancer cells and 3-methyladenine (3-MA), an autophagy inhibitor, countervailed the promoting role of PDK4 interference in ferroptosis in breast cancer cells. Furthermore, PDK4 knockdown activated ASK1/JNK pathway and ASK1 inhibitor (GS-4997) partially abrogated the impacts of PDK4 absence on the autophagy and ferroptosis in breast cancer cells. Conclusion: To sum up, deficiency of PDK4 activated ASK1/JNK pathway to stimulate autophagy-dependent ferroptosis in breast cancer.Keywords
Funding Information
- Taizhou Science and Technology Plan Project 2021 (21ywa37)
- Zhejiang Province Basic Public Welfare Research Program Project 2020 (LGF20H280008)
This publication has 42 references indexed in Scilit:
- Programmed cell death: Past, present and futureBiochemical and Biophysical Research Communications, 2022
- Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progressionPharmacology & Therapeutics, 2022
- Autophagy‐Dependent Ferroptosis as a Therapeutic Target in CancerChemMedChem, 2021
- ASK1 inhibition: a therapeutic strategy with multi-system benefitsJournal of Molecular Medicine, 2020
- Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseasesBiochimica et Biophysica Acta (BBA) - General Subjects, 2019
- Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAMBreast Cancer, 2019
- Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenaseInternational Journal of Cancer, 2018
- Targeting autophagy in cancerCancer, 2018
- Ferroptosis: process and functionCell Death & Differentiation, 2016
- Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK PathwayJournal of Cellular Physiology, 2014